These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38986667)

  • 1. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
    Lopez J; Liu Y; Butler J; Del Prato S; Ezekowitz JA; Lam CSP; Marwick TH; Rosenstock J; Tang WHW; Perfetti R; Urbinati A; Zannad F; Januzzi JL; Ibrahim NE
    J Am Coll Cardiol; 2024 Jul; 84(3):233-243. PubMed ID: 38986667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
    Januzzi JL; Del Prato S; Rosenstock J; Butler J; Ezekowitz J; Ibrahim NE; Lam CSP; Marwick T; Wilson Tang WH; Liu Y; Mohebi R; Urbinati A; Zannad F; Perfetti R
    Cardiovasc Diabetol; 2024 Feb; 23(1):49. PubMed ID: 38302936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
    Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Rosenstock J; Tang WHW; Zannad F; Lawson F; Perfetti R; Urbinati A
    Am Heart J; 2023 Feb; 256():25-36. PubMed ID: 36372245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
    Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Perfetti R; Rosenstock J; Solomon SD; Tang WHW; Zannad F
    J Am Coll Cardiol; 2024 Jul; 84(2):137-148. PubMed ID: 38597864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center.
    Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR
    BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.
    Ibrahim NE; Piña IL; Camacho A; Bapat D; Felker GM; Maisel AS; Butler J; Prescott MF; Abbas CA; Solomon SD; Januzzi JL;
    Circ Heart Fail; 2020 Nov; 13(11):e007829. PubMed ID: 33016100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
    Segar MW; Khan MS; Patel KV; Butler J; Tang WHW; Vaduganathan M; Lam CSP; Verma S; McGuire DK; Pandey A
    J Am Coll Cardiol; 2021 Oct; 78(16):1587-1598. PubMed ID: 34649696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial-Ethnic disparities in stroke prevalence among patients with heart failure.
    Ibeh C; Tom SE; Marshall RS; Elkind MSV; Willey JZ
    J Clin Neurosci; 2024 May; 123():173-178. PubMed ID: 38583373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial).
    Trippe BS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Oyer DS
    Curr Med Res Opin; 2012 Jul; 28(7):1203-11. PubMed ID: 22509859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in Heart Failure Outcomes: Evidence From the Tele-HF Trial (Telemonitoring to Improve Heart Failure Outcomes).
    Qian F; Parzynski CS; Chaudhry SI; Hannan EL; Shaw BA; Spertus JA; Krumholz HM
    JACC Heart Fail; 2015 Jul; 3(7):531-538. PubMed ID: 26160368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age Differences in Racial/Ethnic Disparities in Preventable Hospitalizations for Heart Failure in Connecticut, 2009-2015: A Population-Based Longitudinal Study.
    Doshi RP; Yan J; Aseltine RH
    Public Health Rep; 2020 Jan; 135(1):56-65. PubMed ID: 31747337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial ethnic differences in type 2 diabetes treatment patterns and glycaemic control in the Boston Area Community Health Survey.
    Goonesekera SD; Yang MH; Hall SA; Fang SC; Piccolo RS; McKinlay JB
    BMJ Open; 2015 May; 5(5):e007375. PubMed ID: 25967997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.
    Roberts TJ; Burns AT; MacIsaac RJ; MacIsaac AI; Prior DL; La Gerche A
    Cardiovasc Diabetol; 2018 Mar; 17(1):44. PubMed ID: 29571290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/Ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure.
    Krim SR; Vivo RP; Krim NR; Qian F; Cox M; Ventura H; Hernandez AF; Bhatt DL; Fonarow GC
    JACC Heart Fail; 2013 Aug; 1(4):345-352. PubMed ID: 24621938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.
    Saremi A; Schwenke DC; Bahn G; Ge L; Emanuele N; Reaven PD;
    Metabolism; 2015 Feb; 64(2):218-25. PubMed ID: 25456099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic differences in quality of life in persons with heart failure.
    Riegel B; Moser DK; Rayens MK; Carlson B; Pressler SJ; Shively M; Albert NM; Armola RR; Evangelista L; Westlake C; Sethares K;
    J Card Fail; 2008 Feb; 14(1):41-7. PubMed ID: 18226772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry.
    Powell-Wiley TM; Ngwa J; Kebede S; Lu D; Schulte PJ; Bhatt DL; Yancy C; Fonarow GC; Albert MA
    JACC Heart Fail; 2018 Mar; 6(3):233-242. PubMed ID: 29428434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure.
    Thomas KL; Hernandez AF; Dai D; Heidenreich P; Fonarow GC; Peterson ED; Yancy CW
    Am Heart J; 2011 Apr; 161(4):746-54. PubMed ID: 21473975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.